Latest Insider Transactions at Bei Gene, Ltd. (BGNE)
This section provides a real-time view of insider transactions for Bei Gene, Ltd. (BGNE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BeiGene, Ltd. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BeiGene, Ltd.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 02
2018
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
5,814,100
+49.56%
|
$627,922,800
$108.0 P/Share
|
|
Jun 06
2018
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
37,160
+0.15%
|
-
|
|
Jan 18
2018
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
1,980,198
+28.22%
|
$199,999,998
$101.0 P/Share
|
|
Oct 13
2017
|
Baker Bros. Advisors LP |
BUY
Other acquisition or disposition
|
Direct |
14,204
+50.0%
|
-
|
|
Oct 13
2017
|
Baker Bros. Advisors LP |
SELL
Other acquisition or disposition
|
Indirect |
49,200
-100.0%
|
-
|
|
Feb 08
2016
|
Merck & Co., Inc. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
7,942,314
+50.0%
|
-
|
|
Feb 08
2016
|
Merck & Co., Inc. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
23,646,724
+50.0%
|
-
|